Ledger.Open graph →
SEC Form D · filed January 8, 2025

Luminary Therapeutics, Inc

Offering
$5.9M
Sold
$5.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Minneapolis, MN
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

John Wells · Minneapolis, MNDirectorJames Haymaker · Minneapolis, MNDirector · PromoterTracey Lodie · Minneapolis, MNDirectorMark Chance · Minneapolis, MNDirectorJeff Liter · Minneapolis, MNExec · Director · PromoterJeff Ross · Minneapolis, MNDirectorJeff Ross · Minneapolis, MNDirectorDouglas E. Mark · MINNEAPOLIS, MNExec · Director · PromoterJason Gelberd · West Palm Beach, FLDirectorBenjamin A. Lincoln · Santa Monica, CADirectorC. R. Carter · Atlanta, GADirectorMichael Falk · West Palm Beach, FLDirector · PromoterMichael Aceti · Needham, MADirectorDean Eliott · Needham, MADirectorSteven J. Speck, Ii · BOWLING GREEN, OHExec · Director · PromoterEvan Zemsky · New York, NYDirectorMark S. Feldman · Dallas, TXDirector · PromoterDavid R. Johnson · Rio Rancho, NMDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗